Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients

NCT05338177 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

OTHER: Immunosuppression reduction
OTHER: No immunosuppression reduction

Sponsor

Medical University of Vienna